Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXAMINE-CAD: Bisoprolol vs Diltiazem in Non-obstructive CAD
NCT05294887Phase 4Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2022
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of bisoprolol, diltiazem in non-obstructive coronary artery disease, angina pectoris, sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
bisoprololdiltiazem
03
Conditions
non-obstructive coronary artery diseaseangina pectoris
Beyond the preview
Go deeper on NCT05294887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294887.